CytoMed Therapeutics (GDTC) P/E (2023 - 2026)
CytoMed Therapeutics (GDTC) P/E from Apr 14, 2023 to Jul 20, 2026. The TTM CytoMed Therapeutics (GDTC) P/E is -2.99. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of CytoMed Therapeutics (GDTC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.99 | -28.84% |
| 2025 | -4.20 | -69.05% |
| 2024 | -13.59 | -11.26% |
| 2023 | -15.31 | N/A |
Comparison CytoMed Therapeutics (GDTC) P/E with competitors
CytoMed Therapeutics (GDTC) P/E is -2.99.